Stock Events

Stock Events

PreveCeutical Medical 

$0.010800
6
-$0.00-25.72% Wednesday 17:59

Statistics

Day High
0.0108
Day Low
0.0108
52W High
0.0412
52W Low
0.0038
Volume
10,000
Avg. Volume
17,492
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Mar 10
$0.40
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30SepExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0
-0
-0
0
Expected EPS
N/A
Actual EPS
-0.0012

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-855,540.3Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PRVCF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap153.04M
Aurora Cannabis
ACB
Mkt Cap181.49M
Aurora Cannabis is a major player in the production and distribution of medical cannabis, directly competing with PreveCeutical's cannabis-based product development.
Canopy Growth
CGC
Mkt Cap433.71M
Canopy Growth Corporation is a well-known cannabis company that also focuses on medical cannabis products, competing with PreveCeutical's market.
Tilray Brands
TLRY
Mkt Cap571.47M
Tilray engages in research, cultivation, production, and distribution of medical cannabis and cannabinoids, which competes with PreveCeutical's offerings.
Cronos Group
CRON
Mkt Cap1.01B
Cronos Group is involved in the production and sale of cannabis in multiple international markets, competing with PreveCeutical's cannabis-based products.

About

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development of preventive and therapeutic products derived from organic and nature-identical compounds; synthesized Nature Identical; Sol-Gel Nose-to-Brain delivery platform for Parkinson's disease; develops cannabinoid-based nose-to-brain delivery system for the relief of a various ailments, including pain, inflammation, seizures, and neurological disorders; peptide library synthesis, pharmacological evaluation, alongside pharmacokinetic assessment, and determinations in animal models of pain and inflammation; and non-addictive analgesic peptides for pain management. It also involved in licensing, branding, and marketing nutraceutical and wellness products; Sol-Gel platform; and peptide program. PreveCeutical Medical Inc. is headquartered in West Vancouver, Canada.
Show more...
CEO
Mr. Stephen Van Deventer
Employees
7
Country
United States
ISIN
CA74143C1068

Listings

MU
DE
18H.MU
STU
DE
18H.STU
STU
DE
18H0.STU
CN
CA
PREV.CN

0 Comments

Share your thoughts

FAQ

What is PreveCeutical Medical stock price today?▼
The current price of PRVCF is $0.01 USD — it has decreased by -25.72% in the past 24 hours. Watch PreveCeutical Medical stock price performance more closely on the chart.
What is PreveCeutical Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange PreveCeutical Medical stocks are traded under the ticker PRVCF.
Is PreveCeutical Medical stock price growing?▼
PRVCF stock has risen by +18.68% compared to the previous week, the month change is a +20% rise, over the last year PreveCeutical Medical has showed a -57.14% decrease.
What were PreveCeutical Medical earnings last quarter?▼
PRVCF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is PreveCeutical Medical revenue for the last year?▼
PreveCeutical Medical revenue for the last year amounts to 0 USD.
What is PreveCeutical Medical net income for the last year?▼
PRVCF net income for the last year is -855,540.3 USD.
Does PreveCeutical Medical pay dividends?▼
Yes, PRVCF dividends are paid annual. The last dividend per share was 0.4 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does PreveCeutical Medical have?▼
As of June 28, 2026, the company has 7 employees.
In which sector is PreveCeutical Medical located?▼
PreveCeutical Medical operates in the Health & Wellness sector.
When did PreveCeutical Medical complete a stock split?▼
The last stock split for PreveCeutical Medical was on May 23, 2018 with a ratio of 5:1.
Where is PreveCeutical Medical headquartered?▼
PreveCeutical Medical is headquartered in West Vancouver, United States.